Companion diagnostics are FDA-approved drugs that target a a certain marker or genetic mutation associated with a patient's response.
"For a current listing of FDA approved companion diagnostics click here."
ALK 2p23 rearrangement by FISH
BCR/ABL1 t(9;22) by FISH
BRAF Mutation Analysis by Next Generation Sequencing
c-kit protein by IHC
Chronic Lymphocytic Leukemia (CLL) Panel by FISH
EGFR Mutation Analysis by Next Generation Sequencing
HER2 by IHC
HER2 Gastric by IHC
HER2/neu breast cancer by FISH
HER2/neu gastric cancer by FISH
KRAS Mutation Analysis by Next Generation Sequencing
PD-L1 by IHC